Sarcomatoid carcinoma of the urinary bladder: A case report with immunohistochemical and molecular genetic analysis

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 547-553

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Sarcomatoid carcinoma; Urinary bladder

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P53; PROTEIN P63; STEM CELL FACTOR; SYNAPTOPHYSIN; VIMENTIN;

AGED; ARTICLE; BLADDER CARCINOMA; CASE REPORT; CYSTECTOMY; ENDOSCOPY; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; SARCOMA; TRANSITIONAL CELL CARCINOMA;

EID: 77956892830     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9247-3     Document Type: Article

References (26)

1. Torenbeek R, Biomjous CE, de Bruin PC, Newling DW, Meijer CJ. Sarcomatoid carcinoma of the urinary bladder: clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol. 1994;18:241-9.
2. Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, et al. Carcinomasarcoma and sarcomatoid carcinoma of the bladder: clinicopathologic study of 41 cases. J Urol. 1998;159:1497-503.
3. Serio G, Zampatti C, Ceppi M. Spindle and giant cell carcinoma of the urinary bladder: a clinicopathological light microscopical and immunohistochemical study. Br J Urol. 1995;75:167-72.
4. Jones EC, Young RH. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Mod Pathol. 1997; 10:908-16.
5. Young RH, Wick MR, Mills SE. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic analysis of 12 cases andreview of the literature. Am J Clin Pathol. 1988;90:653-61.
6. Ikegami H, Iwasaki H, Ohjimi Y, Takeuchi T, Ariyoshi A, Kikuchi M. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients. Hum Pathol. 2000;31:332-40.
7. Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271-5.
8. Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y.Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740-6.
9. Terada T. Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of c-kit gene. World J Gastroenterol. 2008;14:7256-9.
10. Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Pathol. 2009;28:29-33.
11. Terada T. Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. Int J Gynecol Pathol. 2009;28:98-100.
12. Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol Int. 2006;56:1-9.
13. Losota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diang Pathol. 2006; 23:91-101.
14. Miettinen M, Lasota J. Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466-78.
15. Young RH, Wick MR. Transitional cell carcinoma of the urinary bladder with pseudosarcomatous stroma. Am J Clin Pathol. 1988;90:216-9.
16. Pacchioni D, Bosco M, Allia E, Mussa B, Mikuz G, Bussolati G. Microcystic urothelial cell carcinoma with neuroendocrine differentiation arising in renal pelvis. Report of a case. Virchows Arch. 2009;454(2):223-7.
17. Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, et al. Utility of a comprehensive immunohistochemical panelin the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol. 2009;33(1):99-105.
18. Kargi A, Gurel D, Tuna B. The diagnostic values of TTF-1, CK5/ 6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol. 2007;15:415-20.
19. Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, et al. P63 and TTF-1 immunostaining: a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;119:696-702.
20. Comperat E, Bieche I, Dargere D, Ferlicot S, Laurendeau I, Benoit G, et al. p63 gene expression study and early bladder carcinogenesis. Urology. 2007;70:459-62.
21. Comperat E, Camparo P, Haus R, Chartier-Kastler E, Bart S, Delcourt A, et al. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma: a tissue microarray study of 158 cases. Virchows Archiv. 2006;448:319-24.
22. Mitra AP, Birkhahn M, Cote RJ. P53 and retinoblastoma pathways in bladder carcinoma. World J Urol. 2007;25:563-71.
23. Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y. Ki-67 is an independent predictor of gall bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.Clin Cancer Res. 2006;12:7369-77.
24. Hailemarriaqm S, Gaspert A, Komminoth P, Tamboli P, Amin M. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol. 1998;11:1016-20.
25. Bollito ER, Pacchioni D, Lopes-Beltran A, Volante M, Terrone C, Casetta G, et al. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Anal Quant Cytol Histol. 2005;27:218-24.
26. Bertaccini A, Marchiori D, Cricca A, Garofalo M, Giovannini C, Manferrari F, et al. Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. Anticancer Res. 2008;28:1369-72.